Circulating Tumor Cells

Faculty
SUPPORTED BY AN UNCONDITIONAL EDUCATIONAL
SPONSORSHIP FROM
Updating on
Circulating
Tumor Cells
Amadori Alberto, University of Padova, IOV-IRCCS, Padova, Italy
Basso Umberto, IOV-IRCCS, Padova, Italy
Buonocore Caterina, Agency for the Promotion of European Research,
Roma, Italy
in cancer patients
management
Cappelletti Maria Rosa, Istituti Ospitalieri Cremona, Italy
2 nd
20
14
Chiarion-Sileni Vanna, IOV-IRCCS, Padova, Italy
be
r2
Cristofanilli Massimo, Thomas Jefferson University, Kimmel Cancer Center,
Philadelphia, USA
Ijzerman Maarten, HTSR University of Twente, Netherlands
Munzone Elisabetta, IEO, Milano, Italy
Opocher Giuseppe, IOV-IRCCS, Padova, Italy
te
Tartarone Alfredo, IRCCS-CROB, Rionero in Vulture (PZ), Italy
Terstappen Leon, HTSR University of Twente, Netherlands
CONFERENCE VENUE
Torri Valter, IRCCS-Mario Negri Institute, Milano, Italy
Auditorium San Gaetano
Via Altinate, 71- Padova
Zagonel Vittorina, IOV-IRCCS, Padova, Italy
Zamarchi Rita, IOV-IRCCS, Padova, Italy
ep
ECM - CONTINUING MEDICAL EDUCATION (C.M.E.)
FOR ITALIAN PARTECIPANTS ONLY
3 C.M.E. credits have been assigned for: biologist, pharmacist, medical
technician biomedical laboratory and medical radiology, doctor (all
medical disciplines), nurse.
Pantano Francesco, University Campus Bio-Medico, Roma, Italy
y,
S
There is no registration fee, but advanced registration is required.
All registration must be submitted online:
www.events-communication.net/circulatingtumorcells
Official language is English.
da
Grisanti Salvatore, Spedali Civili di Brescia, Italy
REGISTRATION
on
Gennari Alessandra, Galliera Hospital, Genova, Italy
M
Gazzaniga Paola, La Sapienza University, Roma, Italy
m
Garrou Diletta, San Luigi Gonzaga Hospital, Orbassano, Italy
ORGANIZING SECRETARIAT
Events
congress&communication
Via Mantegna, 1 - 60019 Senigallia (AN)
Tel +39 071.7930220 - Fax +39 071.9252094
[email protected]
www.events-communication.net
PADOVA, Auditorium San Gaetano
p
INTRODUCTION
The meeting aims to update the participants on the use of the CTC assay in
cancer patients, ten years later the first published report on its prognostic
and predictive value in metastatic breast cancer.
To this purpose, we invited the speakers among the Italians who have
already used the CTCs in different cancers.
Furthermore, we will open the seminar with talks by the greatest CTC
experts to give an international-scale profile to the conference.
The focus of the meeting will be as following:
1) To sharing the knowledge of European metanalysis results on the CTC
use in MBC;
2) To involve all stakeholders in debating the use of CTC assay as
companion diagnostic, including: the health professionals, the Health
Technology Assessment service of public hospitals of Veneto region, the
Regional authorities that establish the reimbursement of new diagnostic
tests, the regulatory authorities of the Italian drug agency;
3) To present the opportunities offered by the European financial support
(Horizon 2020) toward proposals of translational medicine for cancer
patients that include the CTC assay or the study of circulating compartment.
Through this initiative, we expect to increase the network of our research
collaborations around the CTC theme.
ORGANIZING COMMITEE
Dr.ssa Rita Zamarchi
U.O.C. Immunologia e Diagnostica
Molecolare Oncologica
IOV-IRCCS Padova
r
o
8.30
Participants’ Registration
9.00 Welcome address
General Manager IOV-IRCCS
Scientific Director IOV-IRCCS
1st SESSION
CHAIRS: A. Amadori, G. Opocher
9.15 CTCs and breast cancer ten years later
M. Cristofanilli
9.45
The biomarkers in the target drug era
V. Torri
10.15
New perspectives in CTCs investigation
L. Terstappen
10.45 Discussion
11.00
Coffee break
2nd SESSION
CHAIRS: V. Zagonel, R. Zamarchi
11.15
Prognostic value of CTC detection in high-risk Non-Muscle
Invasive Bladder Cancer
P. Gazzaniga
11.35
RANK expression on CTCs in metastatic breast cancer
F. Pantano
11.55 Employ of CTCs in clinical trials: the Myme study experience
A. Gennari
12.15
Economic impact of news biomarkers in the management
of cancer patients
M. Ijzerman
12.45 Discussion
13.15
Lunch
g
r
a
m
3rd SESSION
CHAIR: V. Chiarion-Sileni
14.15
A case report: detection of EML4-ALK positive CTCs in an
adenocarcinoma of lung
A. Tartarone
14.30 A case report: CTC detection in a locally advanced head and neck cancer
S. Grisanti
14.45 A case report: CTC use in adjuvant setting
E. Munzone
15.00 A case report: CTCs’ changes in a MBC patients under
zoledronic acid (ZA)
M. R. Cappelletti
15.15
CTC prostate cancer in patients with high risck prostate cancer undergoing radical robotic prostatectomy
D. Garrou
15.30 A case report: changes of CTC and CEC levels in a
mRCC cancer patient under pazopanib treatment
U. Basso
15.45 A case report: detection of KIT mutation in
Circulating Melanoma Cells (CMCs)
V. Chiarion-Sileni
16.00 New topic for greater opportunities in drafting proposals
for NCP Horizon 2020 Health programme
C. Buonocore
16.30 Round table with the experts
V. Chiarion-Sileni, M. Cristofanilli, P. Gazzaniga,
A. Gennari, F. Pantano
17.30 Closing remarks and ECM test

Download Report